Sponsor Led Roundtable: Addressing Manufacturing Challenges with Gene-Editing Technologies for iPSC Therapeutics
25 Jun 2024
Salon A
iPSCs Technology
![Sponsor Led Roundtable: Addressing Manufacturing Challenges with Gene-Editing Technologies for iPSC Therapeutics](https://cdn.asp.events/CLIENT_HubXchan_638DBA0F_0C6E_8D3C_A444829FC0C4B73E/sites/HubXChange/media/libraries/experts/Akron-Biotech.png/fit-in/1500x9999/filters:no_upscale())
- What are the manufacturing implications of the recent FDA guidelines from January 2024 on “Human Gene Therapy Products Incorporating Human Genome Editing”?
- How do manufacturing requirements differ for gene-editing of master cell banks versus drug substances/drug products?
- How can gene-editing technologies be manufactured to meet appropriate quality attributes?
Industry Expert